Skip to main content
Erschienen in: Surgery Today 3/2012

01.03.2012 | Original Article

Clinical implications of the margin cytology findings and margin/tumor size ratio in patients who underwent pulmonary excision for peripheral non-small cell lung cancer

verfasst von: Noriyoshi Sawabata, Hajime Maeda, Akihide Matsumura, Mitsunori Ohta, Meinoshin Okumura, The Thoracic Surgery Study Group of Osaka University

Erschienen in: Surgery Today | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

A pulmonary wedge resection is useful for the treatment of peripheral non-small cell lung cancer (NSCLC). The margin/tumor size ratio (M/T) is a predictor of positive margin cytology findings in these procedures, although the long-term clinical implications remain unclear. This relationship was investigated in this study.

Methods

Thirty-seven cases with a high surgical risk without additional pulmonary resection were selected from those accrued in a multicenter prospective study of optimal margin distance for pulmonary excision of peripheral NSCLC and followed for more than 5 years (range 5.3–14 years).

Results

Both the M/T and margin cytology findings were indicators of cancer recurrence and survival. All seven cases of surgical margin recurrence had a cytology-positive surgical margin. The 5-year survival rate was 54.2% (n = 24) for M/T < 1 and 84.6% for M/T ≥ 1 (n = 13, P = 0.05), while it was 38.5% for positive margin (n = 13) and 79.2% for negative margin (n = 24) cases (P = 0.001). In addition, the margin cytology findings were an independent prognostic factor.

Conclusion

A pulmonary wedge resection for peripheral NSCLC should result in a negative malignant margin, which might be obtained from a sufficient tumor margin ratio of M/T ≥ 1.
Literatur
1.
Zurück zum Zitat Robinson LA, Ruckdeschel JC, Wagner H Jr, Stevens CW, American College of Chest Physicians. Treatment of non-small cell lung cancer-Stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132S:234s–42s. Robinson LA, Ruckdeschel JC, Wagner H Jr, Stevens CW, American College of Chest Physicians. Treatment of non-small cell lung cancer-Stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132S:234s–42s.
2.
Zurück zum Zitat Fukui T, Mitsudomi T. Small peripheral lung adenocarcinoma: clinicopathological features and surgical treatment. Surg Today. 2010;40:191–8.PubMedCrossRef Fukui T, Mitsudomi T. Small peripheral lung adenocarcinoma: clinicopathological features and surgical treatment. Surg Today. 2010;40:191–8.PubMedCrossRef
3.
Zurück zum Zitat Okada M, Koike T, Higashiyama M, Yamato Y, Kodama K, Tsubota N. Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study. J Thorac Cardiovasc Surg. 2006;132:769–75.PubMedCrossRef Okada M, Koike T, Higashiyama M, Yamato Y, Kodama K, Tsubota N. Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study. J Thorac Cardiovasc Surg. 2006;132:769–75.PubMedCrossRef
4.
Zurück zum Zitat Sawabata N, Karube Y, Umezu H, Tamura M, Seki N, Ishihama H, et al. Cytologically malignant margin without continuous pulmonary tumor lesion: cases of wedge resection segmentectomy and lobectomy. Interact Cardiovasc Thorac Surg. 2008;7:1044–8.PubMedCrossRef Sawabata N, Karube Y, Umezu H, Tamura M, Seki N, Ishihama H, et al. Cytologically malignant margin without continuous pulmonary tumor lesion: cases of wedge resection segmentectomy and lobectomy. Interact Cardiovasc Thorac Surg. 2008;7:1044–8.PubMedCrossRef
5.
Zurück zum Zitat Sawabata N, Matsumura A, Ohota M, Maeda H, Hirano H, Nakagawa K, Thoracic Surgery Study Group of Osaka University, et al. Cytologically malignant margins of wedge resected stage I non-small cell lung cancer. Ann Thorac Surg. 2003;74:1953–7.CrossRef Sawabata N, Matsumura A, Ohota M, Maeda H, Hirano H, Nakagawa K, Thoracic Surgery Study Group of Osaka University, et al. Cytologically malignant margins of wedge resected stage I non-small cell lung cancer. Ann Thorac Surg. 2003;74:1953–7.CrossRef
6.
Zurück zum Zitat Higashiyama M, Kodama K, Takami K, Higaki N, Nakayama T, Yokouchi H. Intraoperative lavage cytologic analysis of surgical margins in patients undergoing limited surgery for lung cancer. J Thorac Cardiovasc Surg. 2003;125:101–7.PubMedCrossRef Higashiyama M, Kodama K, Takami K, Higaki N, Nakayama T, Yokouchi H. Intraoperative lavage cytologic analysis of surgical margins in patients undergoing limited surgery for lung cancer. J Thorac Cardiovasc Surg. 2003;125:101–7.PubMedCrossRef
7.
Zurück zum Zitat Sawabata N, Ohta M, Matsumura A, Nakagawa K, Hirano H, Maeda H, et al. Optimal distance of malignant negative margin in excision of non-small cell lung cancer: a multicenter prospective study. Ann Thorac Surg. 2004;77:415–20.PubMedCrossRef Sawabata N, Ohta M, Matsumura A, Nakagawa K, Hirano H, Maeda H, et al. Optimal distance of malignant negative margin in excision of non-small cell lung cancer: a multicenter prospective study. Ann Thorac Surg. 2004;77:415–20.PubMedCrossRef
9.
Zurück zum Zitat Lewis RJ, Caccavale RJ, Sisler GE, Mackenzie JW. Video-assisted thoracic surgical resection of malignant lung tumors. J Thorac Cardiovasc Surg. 1992;104:1679–85.PubMed Lewis RJ, Caccavale RJ, Sisler GE, Mackenzie JW. Video-assisted thoracic surgical resection of malignant lung tumors. J Thorac Cardiovasc Surg. 1992;104:1679–85.PubMed
10.
Zurück zum Zitat Sawabata N, Mori T, Iuchi K, Maeda H, Ohta M, Kuwahara O. Cytologic examination of surgical margin of excised malignant pulmonary tumor: methods and early results. J Thorac Cardiovasc Surg. 1999;117:618–9.PubMedCrossRef Sawabata N, Mori T, Iuchi K, Maeda H, Ohta M, Kuwahara O. Cytologic examination of surgical margin of excised malignant pulmonary tumor: methods and early results. J Thorac Cardiovasc Surg. 1999;117:618–9.PubMedCrossRef
11.
Zurück zum Zitat Masasyesva BG, Tong BC, Brock MV, Pilkington T, Goldenberg D, Sidransky D, et al. Molecular margin analysis predicts local recurrence after sublobar resection of lung cancer. Int J Cancer. 2005;113:1022–5.PubMedCrossRef Masasyesva BG, Tong BC, Brock MV, Pilkington T, Goldenberg D, Sidransky D, et al. Molecular margin analysis predicts local recurrence after sublobar resection of lung cancer. Int J Cancer. 2005;113:1022–5.PubMedCrossRef
12.
Zurück zum Zitat El-Sherif A, Gooding WE, Santos R, Pettiford B, Ferson PF, Fernando HC, et al. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis. Ann Thorac Surg. 2006;82:408–15.PubMedCrossRef El-Sherif A, Gooding WE, Santos R, Pettiford B, Ferson PF, Fernando HC, et al. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis. Ann Thorac Surg. 2006;82:408–15.PubMedCrossRef
13.
Zurück zum Zitat Landreneau RJ, Sugarbaker DJ, Mack MJ, Hazelrigg SR, Luketich JD, Fetterman L, et al. Wedge resection versus lobectomy for stage I (T1N0M0) non-small cell lung cancer. J Thorac Cardiovasc Surg. 1997;113:698–700.CrossRef Landreneau RJ, Sugarbaker DJ, Mack MJ, Hazelrigg SR, Luketich JD, Fetterman L, et al. Wedge resection versus lobectomy for stage I (T1N0M0) non-small cell lung cancer. J Thorac Cardiovasc Surg. 1997;113:698–700.CrossRef
14.
Zurück zum Zitat Errett LE, Wilson J, Chiu RC, Munro DD. Wedge resection as an alternative procedure for peripheral bronchogenic carcinoma in poor risk patients. J Thorac Cardiovasc Surg. 1985;90:656–61.PubMed Errett LE, Wilson J, Chiu RC, Munro DD. Wedge resection as an alternative procedure for peripheral bronchogenic carcinoma in poor risk patients. J Thorac Cardiovasc Surg. 1985;90:656–61.PubMed
15.
Zurück zum Zitat Miller JI, Hatcher CR Jr. Limited resection of bronchogenic carcinoma in the patients with marked impairment of pulmonary function. Ann Thorac Surg. 1987;44:340–3.PubMedCrossRef Miller JI, Hatcher CR Jr. Limited resection of bronchogenic carcinoma in the patients with marked impairment of pulmonary function. Ann Thorac Surg. 1987;44:340–3.PubMedCrossRef
16.
Zurück zum Zitat Jensik RJ, Feber LP, Milloy FJ, Monson DO. Segmental resection for lung cancer; a fifteen-year experience. J Thorac Cardiovasc Surg. 1973;66:563–72.PubMed Jensik RJ, Feber LP, Milloy FJ, Monson DO. Segmental resection for lung cancer; a fifteen-year experience. J Thorac Cardiovasc Surg. 1973;66:563–72.PubMed
17.
Zurück zum Zitat Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1996;62:1249–50.CrossRef Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1996;62:1249–50.CrossRef
18.
Zurück zum Zitat Warren WH, Faber LP. Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma Five-year survival and patterns of intrathoracic recurrence. J Thorac Cardiovasc Surg. 1994;107:1087–93.PubMed Warren WH, Faber LP. Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma Five-year survival and patterns of intrathoracic recurrence. J Thorac Cardiovasc Surg. 1994;107:1087–93.PubMed
19.
Zurück zum Zitat Kodama K, Doi O, Higashiyama M, Yokouchi H. Intentional limited resection for selected patients with T1 N0 M0 non-small-cell lung cancer: a single-institution study. J Thorac Cardiovasc Surg. 1997;114:347–53.PubMedCrossRef Kodama K, Doi O, Higashiyama M, Yokouchi H. Intentional limited resection for selected patients with T1 N0 M0 non-small-cell lung cancer: a single-institution study. J Thorac Cardiovasc Surg. 1997;114:347–53.PubMedCrossRef
20.
Zurück zum Zitat Yoshikawa K, Tsubota N, Kodama K, Ayabe H, Taki T, Mori T. Prospective study of extended segmentectomy for small lung tumors: the final report. Ann Thorac Surg. 2002;73:1055–8.PubMedCrossRef Yoshikawa K, Tsubota N, Kodama K, Ayabe H, Taki T, Mori T. Prospective study of extended segmentectomy for small lung tumors: the final report. Ann Thorac Surg. 2002;73:1055–8.PubMedCrossRef
21.
Zurück zum Zitat Keenan RJ, Landreneau RJ, Maley RH Jr, Singh D, Macherey R, Bartley S, et al. Segmental resection spares pulmonary function in patients with stage I lung cancer. Ann Thorac Surg. 2004;78:228–33.PubMedCrossRef Keenan RJ, Landreneau RJ, Maley RH Jr, Singh D, Macherey R, Bartley S, et al. Segmental resection spares pulmonary function in patients with stage I lung cancer. Ann Thorac Surg. 2004;78:228–33.PubMedCrossRef
22.
Zurück zum Zitat Schuchert MJ, Pettiford BL, Keeley S, D’Amato TA, Kilic A, Close J, et al. Anatomic segmentectomy in the treatment of stage I non-small cell lung cancer. Ann Thorac Surg. 2007;84:926–32.PubMedCrossRef Schuchert MJ, Pettiford BL, Keeley S, D’Amato TA, Kilic A, Close J, et al. Anatomic segmentectomy in the treatment of stage I non-small cell lung cancer. Ann Thorac Surg. 2007;84:926–32.PubMedCrossRef
23.
Zurück zum Zitat Fernando HC, Santos RS, Benfield JR, Grannis FW, Keenan RJ, Luketich JD, et al. Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg. 2005;129:261–7.PubMedCrossRef Fernando HC, Santos RS, Benfield JR, Grannis FW, Keenan RJ, Luketich JD, et al. Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg. 2005;129:261–7.PubMedCrossRef
Metadaten
Titel
Clinical implications of the margin cytology findings and margin/tumor size ratio in patients who underwent pulmonary excision for peripheral non-small cell lung cancer
verfasst von
Noriyoshi Sawabata
Hajime Maeda
Akihide Matsumura
Mitsunori Ohta
Meinoshin Okumura
The Thoracic Surgery Study Group of Osaka University
Publikationsdatum
01.03.2012
Verlag
Springer-Verlag
Erschienen in
Surgery Today / Ausgabe 3/2012
Print ISSN: 0941-1291
Elektronische ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-011-0031-6

Weitere Artikel der Ausgabe 3/2012

Surgery Today 3/2012 Zur Ausgabe

Leitlinien kompakt für die Allgemeinmedizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Facharzt-Training Allgemeinmedizin

Die ideale Vorbereitung zur anstehenden Prüfung mit den ersten 24 von 100 klinischen Fallbeispielen verschiedener Themenfelder

Mehr erfahren

Update Allgemeinmedizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.